Contract pharmacy restrictions—and legislation to override them—dominated 340B policy discussions in statehouses and courtrooms across the country this year, as [...] …
Category: Pharma Industry
The 119th Congress’ House Energy and Commerce (E&C) Committee—an influential panel with jurisdiction over the Medicaid and 340B programs—will feature [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Three manufacturers and a drug industry trade group dropped their lawsuits against Kansas’ 340B contract pharmacy access law after the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B Report [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In the first major legal setback for states pursuing contract pharmacy protections, a federal district judge ruled yesterday that West Virginia officials cannot enforce the state’s contract pharmacy access law while three drug industry legal challenges play out.
U.S. District
…
Emerging regulatory conflicts between the Inflation Reduction Act (IRA) and the 340B program may soon force policymakers to enact major [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
AbbVie’s latest move to extend certain 340B contract pharmacy restrictions to federal grantees also appears to target hospitals’ use of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A San Diego-based drugmaker recently notified 340B covered entities of manufacturing and drug code changes for an antibiotic used to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
French pharmaceutical giant Sanofi late yesterday announced it would pause the implementation of its contested 340B rebate plan and become [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Breaking News
HRSA Threatens to Remove Sanofi from 340B Program Over ‘Unapproved’ 340B Rebate Proposal
The federal department that oversees the 340B program told Sanofi late Friday afternoon that it must cease implementation of its [...] …